GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome

MSG-treated SHR presented all metabolic syndrome characteristics, as well as reduced GLUT4 content, which must play a key role in the impaired glycemic homeostasis of the metabolic syndrome.